Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02848313
Brief Title: An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

First Submitted : July 25, 2016
First Submitted that Met QC Criteria : July 25, 2016
First Posted : July 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 5, 2017
Last Update Posted : September 6, 2017